.......

I though Creativity only for designer, now for IT industry also. I am really amazed with your comment

Iot is not based on creativity ? Are you serious ?

Yes, i can say maybe he got business minded but everything he say is just empty and surface.

I read the comment, I really can't stop laugh. My gosh.

JOKER - line

walao, this topic still continue ?

Bro, being offensive to a counter is ok, but don't buta buta tembak.
Don't act smart, karma is smarter than you...

Con or con I don't know. but you really make me laugh man. hahahaha...

Please..... I don't think you even have any IT knowledge.

If anything is like what you speak, then I can tell you 1 thing.
The whole industry don't need IoT, just like your sharing, copy india video, india tech, india nokia., india IoT, india cloud, lol ...

India is famous with tech, Guess everyone know it.

In fact, if you want to comment like an expert, go study how tencent and microsoft work.

If youtube can work, IT, programmer, software engineering will not categories as a high pay job. They can join your partnership to sell Phone Numbers.....

I am just pass by here. I am not sure how good or how bad ARB is but the comment from this user [line] sound just too funny. Guess he is not from this industry. but [acting smart]. This user make my day. Hahahah....

The bom bi bi will come

Keep calm and Steady !!!

Not bad le, After Sung master, here come with RTO.

LIMIT UP ?!!!!!!!

New solar family ?

https://klse.i3investor.com/blogs/blogging2win/2021-09-23-story-h1571678877-Another_solar_related_gem_that_is_YET_to_be_discovered_by_investors.jsp

Market so bad, still standing firm. Nice UWC, super solid

Seems good

Wow, @BilisMasin FULL TIME SPAMMER at Kanger ? So working hard to fight back all comment

https://www.nst.com.my/business/2021/09/725001/kangers-new-acquisition-sung-master-deliver-strong-profit-fy21

KUALA LUMPUR: Bamboo flooring manufacturer Kanger International Bhd is upbeat about its prospects, mainly driven by its acquisition of a 51 per cent stake in building materials supplier Sung Master Holdings Sdn Bhd for RM94.8 million.

"The acquisition of Sung Master will positively enhance our financial performance as Sung Master is a profitable company. For the full-year (ended June 30 2021), we expect Sung Master to deliver an estimated net profit and revenue of about RM20.0 million and RM115.0 million respectively," said Kanger executive director Steven Kuah Choon Ching said.

Kanger said Sung Master had consistently delivered a profitable performance over the past three financial years (FY), from FY ended January 2018 up to the audited 17-month of FY ended June 2021 and the latest unaudited 10-month ended April 2021.

Moreover, Sung Master even paid out dividends totaling RM25.0 million during the periods.

It has also consistently recoded double-digit gross profit margin for the past two financial years with low gearing of 0.63 times and also strong current ratio of 2.4 times , suggesting strong operating cashflow.

For the latest 10-month ended April 30 2021, Sung Master reported an unaudited net profit of RM11.8 million against revenue of RM76.0 million.

Sung Master is mainly involved in the sales and trading of building materials, which include timber flooring, tiles, bulk cement, concrete, locksets and sanitary ware.

Its clients consist of property and construction players as well as engineering consultants.

Kanger recently diversified into the construction business and the acquisition of Sung Master is part of the group's growth strategy to enhance its competitive advantage when bidding for new projects in the construction industry.

"By leveraging on Sung Master's existing network of suppliers, we can source for building materials at relatively competitive prices. This will lead to greater cost efficiencies when tendering for new projects," Kuah said.

Kanger is currently working on construction projects with a combined orderbook of about RM1.0 billion.

It is applying for the Grade 7 contractor licence from the Construction Industry Development Board which will enable it to undertake construction projects of any value.

Kanger has also expanded its portfolio of investment properties with a RM142.9 million acquisition of 126 service apartments units in Antara @ Genting Highlands.

The development of the properties are expected to be completed by 2024.

"Once the service apartment units are completed, the properties will bring in a steady flow of recurring income by way of receiving rental income. "Furthermore, we will also benefit from capital gains when the properties are sold, as we managed to buy these units en-bloc at an attractive price."

"Genting Highlands is an attractive tourist destination for local and international travelers. We are confident that these apartment units will be in high demand once travel restrictions are lifted and tourism activities return to normal," Kuah said.

Kanger's existing bamboo business has been disrupted by the lockdowns in China and Malaysia due to the Covid-19 pandemic which affected sales in the last year.

"We took this time to explore and identify various opportunities to expand our revenue portfolio into new areas that are complementary to our core competencies. In addition to property investment, we also decided to diversify into the construction business," he said.

Kanger is currently undergoing a renounceable rights issue with warrants on the basis of one rights share for every existing share, together with one free detachable warrant for every one rights share subscribed.

At an issue price of RM0.06 per rights share, the exercise could raise gross proceeds of up to RM20.0 million under the minimum case scenario and RM171.7 million under the maximum case scenario.

"We are putting the group on a stronger and resilient foundation and hope our shareholders share in our vision. With the rights issue exercise, our shareholders will have the opportunity to participate in the prospects and future growth of our group," Kuah said.

Since share price started rebound, see what is going on next ba...
Since many people being supportive, add on a bit during closing time

Seriously I don't wish that the CEO got change. Since the current CEO is working pretty good and making turn around to the company.

I like people who use "My understanding" to comment. XD

Whenever Prinsiptek Corp Bhd is on board, the accounting also not that nice la.

Did empty project and lie to the investor.

If you let me choose. I will prefer Ages more. Smoke screen or what, I don't care.
The share price is what everyone concern, at least let u earn few wave at nice timing lo.

Volume come liao ？ Coming two quarter should be outstanding qr.

Vaccine is one dose or two dose but test kits maybe require more than as for checking purpose, guess the demand is there and there are a huge demand that will profit to bioholding. Let see how coming QR will reflected on it

Drop and rise again, queuing @ 6.5sen

Kanger and Dphma seems will leading for market on vaccine
https://www.theedgemarkets.com/article/kanger-enters-deal-buy-five-million-doses-sinopharm-covid19-vaccines

Kanger and Dphma seems will leading for market on vaccine

https://www.theedgemarkets.com/article/kanger-enters-deal-buy-five-million-doses-sinopharm-covid19-vaccines

EFFORTS BY THE COMPANY TO SECURE COVID-19 VACCINE BUSINESS

There are some efforts taken by Kanger to make sure they will successfully enter the Covid-19 distribution business. The chronological list (by date) of the efforts taken are listed below:

1. The Covid-10 vaccine started, when Kanger had entered into a proxy agreement with Shenzhen Public Health Technology Co, Ltd (SZPHT) to procure dealership status from China National Biotec Group Company Ltd (CNBG), which is a subsidiary of China National Pharmaceutical Group Corp (Sinopharm) and distributing it in Southeast Asia.

(Remarks: This agreement has been lapsed because it is only valid until October 8, 2020)

Source: https://www.theedgemarkets.com/article/kanger-seeks-rights-distribute-chinadeveloped-covid19-vaccine-southeast-asia

2. Kanger had entered a collaboration agreement with China-based Sinopharm Group Hunan Changde Medical Co Ltd (Sinopharm Group) for the distribution of Covid-19 vaccines developed by China National Biotech Group Company (CNBG) in Malaysia.

Source: https://www.theedgemarkets.com/article/kanger-seeks-rights-distribute-chinadeveloped-covid19-vaccine-southeast-asia

3. Kanger revealed their final phase of discussion to be a distributor of Covid-19 vaccines for private sector in Malaysia.

Source: https://www.msn.com/en-my/news/berita/kanger-bincang-jadi-pengedar-vaksin-covid-19/ar-BB1bgXxB

4. Kanger International Bhd has received the nod from the National Institutes of Biotechnology Malaysia (NIBM) to distribute Covid-19 vaccines and medical equipment in Malaysia.

Source: https://www.msn.com/en-my/news/national/kanger-gets-greenlight-to-distribute-covid-19-vaccines/ar-BB1bgSm9

5. Kanger International Bhd will receive 10,000 doses of a Covid-19 vaccine developed by state-owned China National Pharmaceutical Group Corp (Sinopharm) for trial purposes.

(Remarks: The first batch of vaccines is expected to arrive in Malaysia on May 2021).

Source: https://www.theedgemarkets.com/article/kanger-receive-10000-doses-sinopharm-covid19-vaccine%C2%A0-may-trial-purposes

6. Kanger Donates RM200,000 To Sabah In Efforts To Combat Covid-19

(Remarks: Is it a type of lobby? )

Source: https://www.businesstoday.com.my/2021/05/21/kanger-international-donates-rm200000-to-sabah-in-efforts-to-combat-covid-19/

7. Kanger International offers 5,000 doses of Sinopharm Covid-19 vaccine to Sabah

(Remarks: Is it another type of lobby? )

Source: http://www.dailyexpress.com.my/news/171588/kanger-international-offers-5-000-doses-of-sinopharm-covid-19-vaccine-to-sabah/

8. MOU with Sabah State Government to obtain Sinopharm Covid-19 vaccines

(Remarks: Will the MOU with Sabah State Government helps the company to obtain approval for Sinopharm Covid-19 vaccine from the government through the National Pharmaceutical Regulatory Agency Negara (NPRA)? )

Source: https://www.malaymail.com/news/malaysia/2021/05/27/sabah-govt-signs-mou-with-kanger-international-to-obtain-sinopharm-covid-19/1977503

https://klse.i3investor.com/blogs/httpsklsei3investorcomM/2021-05-29-story-h1565953920-Kanger_017_The_Bamboo_Flooring_And_Related_Products_Company_Is_Trying_H.jsp

WHAT IS THE EXPECTED RESULTS?



Based on these reports:

Report 1: The Sinopharm Covid-19 vaccine is in the process of being approved in Malaysia, including by the National Pharmaceutical Regulatory Agency (NPRA).

“We will ensure that we obtain the required approvals from relevant authorities before we commence distribution of the Sinopharm vaccines.

“Once approvals are obtained, the people of Sabah will be one of the early recipients of the Sinopharm vaccines,” Kuah said.

(Source: https://www.theedgemarkets.com/article/kanger-signs-mou-sabah-govt-procure-chinas-sinopharm-covid19-vaccines).

Report 2: S Kanger International executive director Steven Kuah told reporters that, “the process of registering the Sinopharm vaccine (with NPRA) has started and we hope to receive some good news on its approval soon.”

(Source: https://www.freemalaysiatoday.com/category/nation/2021/05/27/sabah-signs-mou-with-private-firm-to-obtain-sinopharm-vaccine/ )

Report 3: Covid-19: Those who want to bring in Sinopharm vaccine can register it with NPRA, says Khairy.

(Source: https://www.thestar.com.my/news/nation/2021/05/21/covid-19-those-who-want-to-bring-in-sinopharm-vaccine-can-register-it-with-npra-says-khairy )

Report 4: Supplies through Putrajaya is just one of the options available, and that state governments could source their own as long as they are approved by the National Pharmaceutical Regulatory Agency (NPRA) – says Khairy

(Source: https://malaysia.news.yahoo.com/khairy-says-okay-states-direct-094230051.html )

Report 5: PM says anyone can buy Covid-19 vaccines, as long as approved by NPRA.

(Source: https://www.malaymail.com/news/malaysia/2021/05/23/pm-says-anyone-can-buy-covid-19-vaccines-as-long-as-approved-by-npra/1976473)



Therefore, we are hoping that, sooner Kanger will be successful in securing their objective to be an approved Covid-19 vaccines distributor in Malaysia.



* DISCLAIMER: All the information given is not for buy call or sell call purposes.

EFFORTS BY THE COMPANY TO SECURE COVID-19 VACCINE BUSINESS

There are some efforts taken by Kanger to make sure they will successfully enter the Covid-19 distribution business. The chronological list (by date) of the efforts taken are listed below:

1. The Covid-10 vaccine started, when Kanger had entered into a proxy agreement with Shenzhen Public Health Technology Co, Ltd (SZPHT) to procure dealership status from China National Biotec Group Company Ltd (CNBG), which is a subsidiary of China National Pharmaceutical Group Corp (Sinopharm) and distributing it in Southeast Asia.

(Remarks: This agreement has been lapsed because it is only valid until October 8, 2020)

Source: https://www.theedgemarkets.com/article/kanger-seeks-rights-distribute-chinadeveloped-covid19-vaccine-southeast-asia

2. Kanger had entered a collaboration agreement with China-based Sinopharm Group Hunan Changde Medical Co Ltd (Sinopharm Group) for the distribution of Covid-19 vaccines developed by China National Biotech Group Company (CNBG) in Malaysia.

Source: https://www.theedgemarkets.com/article/kanger-seeks-rights-distribute-chinadeveloped-covid19-vaccine-southeast-asia

3. Kanger revealed their final phase of discussion to be a distributor of Covid-19 vaccines for private sector in Malaysia.

Source: https://www.msn.com/en-my/news/berita/kanger-bincang-jadi-pengedar-vaksin-covid-19/ar-BB1bgXxB

4. Kanger International Bhd has received the nod from the National Institutes of Biotechnology Malaysia (NIBM) to distribute Covid-19 vaccines and medical equipment in Malaysia.

Source: https://www.msn.com/en-my/news/national/kanger-gets-greenlight-to-distribute-covid-19-vaccines/ar-BB1bgSm9

5. Kanger International Bhd will receive 10,000 doses of a Covid-19 vaccine developed by state-owned China National Pharmaceutical Group Corp (Sinopharm) for trial purposes.

(Remarks: The first batch of vaccines is expected to arrive in Malaysia on May 2021).

Source: https://www.theedgemarkets.com/article/kanger-receive-10000-doses-sinopharm-covid19-vaccine%C2%A0-may-trial-purposes

6. Kanger Donates RM200,000 To Sabah In Efforts To Combat Covid-19

(Remarks: Is it a type of lobby? )

Source: https://www.businesstoday.com.my/2021/05/21/kanger-international-donates-rm200000-to-sabah-in-efforts-to-combat-covid-19/

7. Kanger International offers 5,000 doses of Sinopharm Covid-19 vaccine to Sabah

(Remarks: Is it another type of lobby? )

Source: http://www.dailyexpress.com.my/news/171588/kanger-international-offers-5-000-doses-of-sinopharm-covid-19-vaccine-to-sabah/

8. MOU with Sabah State Government to obtain Sinopharm Covid-19 vaccines

(Remarks: Will the MOU with Sabah State Government helps the company to obtain approval for Sinopharm Covid-19 vaccine from the government through the National Pharmaceutical Regulatory Agency Negara (NPRA)? )

Source: https://www.malaymail.com/news/malaysia/2021/05/27/sabah-govt-signs-mou-with-kanger-international-to-obtain-sinopharm-covid-19/1977503

Kanger International Bhd, an investment holding company, engages in the research, development, manufacture, and trade of bamboo flooring and related products in the People's Republic of China. It operates the business across North America, Europe, and Asia. By second halve of the year 2020, Kanger started to explore a plan for a new venture in business: to distribute the Covid-19 vaccines manufactured by Sinopharm in Malaysia. Kanger has tried hard to secure this Covid-19 vaccines business as this new business expected to bring a better results for the company.



THE CURRENT DEVELOPMENT OF KANGER'S BAMBOO BUSINESS

Kanger (017) is a "green" building materials provider, specialising in the manufacturing and trading of bamboo flooring and related products for the residential and commercial markets under its brands 'Kanger' and 'KAR Masterpiece' as well as OEM at the request of its customers. In additional, it also sell strand woven bamboo planks, a semi-finished product from its strand woven bamboo flooring manufacturing process, to furniture and building materials manufacturers as raw materials for their production. The bamboo flooring and related products business is still running well as can be seen at these websites:

1. https://krbamboo.en.china.cn/

2. https://shenzhenkanger1.sell.everychina.com/

3. https://www.tradewheel.com/co/shenzhen-kanger-bamboo-wood-45509/products/



On September 2020, Kanger planned to strengthen their bamboo products business. Kanger is on target to become the world’s largest producer of bamboo products with the commencement of a new high-tech bamboo processing plant and R&D centre, which was developed in collaboration with the local government of Jingzhou, Hunan Province, China. Kanger has accumulated vast experience and strong know-how of the bamboo industry, having been involved in the bamboo processing business over the past 16 years.

(Source: https://www.theborneopost.com/2020/09/10/kanger-aims-to-be-worlds-largest-bamboo-products-producer/)

No wonder many telegram group started to share vaccine related counter la.

Started moving now. Volume getting strong ? Hopefully kanger got show

Nothing special, nvm. Hold for while and see what is happening. After oil and gas, glove, really having chance on vaccine. Keep until , should be ok

Covid case is recently on spiking stage, if they really on going for sabah, That will be great Must be goreng up soon, maybe limit up ?? (Disclaimer: Limit up i say only , but there are really possible de.)

It seems that after lunch is going to spik, there are some group giving out signal ? Reliable ? Don't care la, Get a bit first

I guess I'm a bit offensive but standing still to my personal opinion .

People concern more about the future value or the Current trend ?

Why not both, Solar is not working good ? Then Why Tesla and Alibaba is going this business.

Is about a convert century, data and energy will be what more concern in 5-10 years and even. In Japan, US and China. Tech and Energy is still on trend same goes to Malaysia.

Either PEB will be the leading company for Solar Sector. We will see it. During that time, The concern of everyone is different. Just like now, share price drop, you shout here shout there. But if you are a value investor. This is a company, why not buying it ? Uptrend you make profit, down trend , you make an average down.

Most important is not you buying expensive or cheap, Is you understand The value Behind it like winetime said.

lol, When some said that can't see the "value" and the keep being offensive ? Investor ke? hater ?

Instead of get misleading by those unreliable comment and unknown source.

I agree that Every Investor should watch the video that posted in YouTube regarding the live playback of 12invest blogger and Renikola.

Regarding stock value I think everyone have different opinion, Like Azshah was keep saying that is not fair to this and that and meanwhile those telegram and supporter keep mention about. TP 4-5.

In this, I can just that value is another story, Stock market need included with demand and need also additional come with market trend and market sentiment. Harta, Very good example, past few year was keep staying at 4, Will you buy it ? Most people will refuse to said, This is too expensive but when pandemic on going, Trend and Demands is the main game player.

If everyone going with a simple math, I guess most of everyone is stock guru. No more blogger and Everyone is a billionaire.

Instead of get misleading to reading those comment, Study the value of the company and understand the share Value . lol....

Misunderstanding is ok.... hahaha, Don't misleading.

Nice la, keep remain performance

Yup, instead of solar, they also mentioned that they are more focusing on Renewable energy which I can see the big view and future of PEB.

here you go

https://www.facebook.com/12invest.my/posts/296040055223635

PEB is solid, why not

Tonight is the live, After inject Renikola to PEB is another wave to challenge above

Rakuten Trade Ideas网络研讨会上，来自Pimpinan Ehsan Bhd（5622）和reNIKOLA的管理层Boumhidi Adel，Lim Beng Guan和Khong Ho Ming的重要见解：

-在马来西亚成立最大的可再生能源公司

-运行中的5MWp和38MWp的性能均远超预期，而45MWp将在2021年4月开始运作。330MWp预计将于2022年底由主要的地区EPCC参与者建造（不是任何本地上市的参与者）

-希望在2025年前通过有机增长和并购实现1GWp的目标

-reNIKOLA致力于以ESG为中心的政策

-有在东南亚和亚洲的区域发展的志向

-通过发行新的PEB股份收购reNIKOLA，目标是在2021年第四季度完成

載自Rakuten Trade Ideas网络研讨会上，来自Pimpinan Ehsan Bhd（5622）和reNIKOLA的管理层Boumhidi Adel，Li Ho Ming的重要见解

运行中的5MWp和38MWp的性能均远超预期，而45MWp将在2021年4月开始运作。330MWp预计将于2022年底由主要的地区EPCC参与者建造（不是任何本地上市的参与者）

https://klse.i3investor.com/blogs/12stocktalk/2021-03-10-story-h1542120192.jsp